Immunotherapy for the Treatment of Breast Cancer: Emerging New Data
Lida A Mina,1 Shannon Lim,2 Shakeela W Bahadur,1 Abdul T Firoz3 1Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA; 2Pharmacy Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA; 3Science Department, Arizona State University, Tempe, AZ, USACorrespondence:...
Enregistré dans:
Auteurs principaux: | Mina LA, Lim S, Bahadur SW, Firoz AT |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f81b79e0b475402abd9d4701e7b12d30 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Opportunities for metastatic triple negative breast cancer therapy
par: Inna P. Ganshina, et autres
Publié: (2021) -
Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
par: Mai F. Tolba, et autres
Publié: (2021) -
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
par: Ayoub NM, et autres
Publié: (2019) -
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?
par: Vladislav O. Sarzhevskiy, et autres
Publié: (2021) -
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
par: Pei-Yi Chu, et autres
Publié: (2021)